Tilray Brands

Celebrating Five Years of Growth: Tilray Brands Reflects on Industry Leadership in Canadian Cannabis and Looks Forward to its Future

TORONTO, Oct. 19, 2023 -- Tilray Brands, Inc. ("Tilray" or the "Company") (Nasdaq: TLRY; TSX: TLRY), a leading global cannabis-lifestyle and consumer packaged goods company, is celebrating five years of remarkable growth and industry leadership in the Canadian cannabis market since legalization. Over the past half-decade, Tilray has emerged as the most robust and leading international cannabis Licensed Producer (LP) in Canada with a cannabis market share of approximately 13.4%, inclusive of recent strategic acquisitions of HEXO Corp. and Truss Beverage Co.

Irwin D. Simon, Chairman and CEO, Tilray Brands, Inc. said, "In the span of five years, we have come a long way and despite the many challenges we and our industry have faced, I am proud of what we have created and accomplished across our Canadian cannabis businesses including Aphria, HEXO, Truss Beverages, and Tilray Brands. Over the next five years, we look forward to working with the Canadian government to help strengthen our industry as we have plenty of learnings to capitalize on as we write the next chapter and evolution of Canadian cannabis.”

Mr. Simon continued, “In Canada, we are building the model of a safe and responsible high growth industry that other countries can learn from and emulate as cannabis legalization continues to proliferate across the globe. Tilray Brands is committed to leading the global cannabis industry in quality, innovation, brands, and consumer insight while building long-term shareholder value.”

Reflecting on the journey, Blair MacNeil, President, Tilray Canada, added, “From the outset, our mission has been deeply understanding our consumers and ensuring we develop brands and products that resonate with both the adult-use and medical markets. This consumer-centric approach has been the cornerstone of our innovation and success, guiding every decision we make and driving our continuous growth. Tilray’s strength in Canada spans across categories; we are ranked #1 in sales for cannabis Flower, Oils, Concentrates, and THC beverages, #2 in Pre-Rolls, #4 in Vape, and among the top 10 in all other major categories. We have grown our Canadian cannabis revenue by 16.5% this past quarter alone and maintained our #1 position in leading cannabis market share.”

Significant milestones marking Tilray's five-year leadership in the Canadian cannabis industry include the acquisition of Broken Coast in 2018; the monumental business combination of Tilray and Aphria in 2021, creating the Tilray Brands—a global cannabis and CPG leader, as well as the growth and expansion of Tilray’s medical cannabis portfolio encompassing four unique medical brands: Broken Coast, Aphria Medical, Tilray, and Symbios; and the transformative acquisition of HEXO Corp. and acquisition of Truss Beverage Co. earlier this year, further solidifying the Company’s market dominance.

Tilray Brands’ comprehensive Canadian cannabis portfolio includes:

  • Good Supply:

    • Good Supply is one of Canada's leading cannabis brands and has been recognized as #1 in flower, and best-selling pre-rolls, vapes, and concentrates, and has become a favourite among consumers and budtenders.

  • Redecan:

    • Redecan is a Canadian cannabis company with over 30 years in agriculture. Redecan’s tools are fresh water and sunshine, farming the way it has been done for hundreds of years.

  • Broken Coast:

    • Broken Coast is a heritage cannabis brand widely recognized for setting the standard for craft cannabis in Canada.

  • Canaca:

    • CANACA is a proudly Canadian brand that indulges your unapologetic love for Canada and cannabis. We are all about elevated adventures and expanding your horizons.

  • Chowie Wowie:

    • Chowie Wowie is a cannabis edible brand that believes edibles should be fun, safe, tasty, and consistent. And most important of all, enjoyed with friends.

  • RIFF:

    • RIFF was born out of the love for a good joint effort. Committed to providing quality cannabis products and encouraging creativity, RIFF has been widely recognized in the Canadian landscape as a brand that has always supported creative explorers and connoisseurs, serving as a leader in curating and contributing to local events and artist showcases that reflect the RIFF lifestyle.

  • Solei:

    • Solei is a leading cannabis wellness and lifestyle brand with thoughtfully designed products for curating sensorial experiences based on what you need, when you need it, entirely on your terms.

  • Original Stash:

    • Original Stash is straightforward and uncomplicated. That’s the way your stash should be. Grown in a controlled environment, Original Stash is a blend of high-quality weed sold for a lot less than you’d expect.

  • Hexo:

    • HEXO flower is sun grown in hybrid greenhouses and is methodically trimmed, dried and cured at HEXO’s flagship facility. Our commitment to quality shines with this flower product, grown and packaged in a highly controlled environment for a consistent and superior consumer experience.

  • XMG:

    • XMG is one of Canad’s winning cannabis beverage brands offering a range of bold drink flavours for the avid consumer.

  • Mollo:

    • Mollo offers a collection of cannabis infused beverages that embrace clean, crisp, non-alcoholic flavours reminiscent of popular lager profiles, and is best known in Canada for its first-of-its-kind balanced offering of 10mg THC and 10mg CBG.

  • Bake Sale:

    • Bake Sale All Purpose Flower is a blended product that offers high-quality buds with pungent terpene aromas, approachable THC levels, and a variety of options for consumption.

  • The Batch:

    • The Batch believes in keeping cannabis simple and good, serving customers consistently reliable product, with at affordable prices.

  • Tilray Medical:

    • Tilray is the global leader in the advancement of cannabinoid-based medicine, with a keen focus on providing research-backed medical cannabis products to physicians, pharmacies, and patients, around the world.

  • Aphria Medical:

    • Aphria is a Licensed Producer of medical cannabis products. We are truly powered by sunlight; our quality medical cannabis is 100% greenhouse-grown, allowing for the most natural conditions for quality products.

  • Symbios:

    • Symbios was designed with quality, care, and affordability in mind, to help support patients on their medical and wellness journey.

  • Dubon:

    • A vibrantly Québécois cannabis brand and champion of inspired, creative living. Dubon offers master-crafted cannabis strains as whole flower and pre-rolls, exclusively available through the Société québécoise du cannabis in Québec (SQDC).

About Tilray Brands

Tilray Brands, Inc. (Nasdaq: TLRY; TSX: TLRY), is a leading global cannabis-lifestyle and consumer packaged goods company with four distinct and complementary business segments including medical and adult-use cannabis, medical distribution, wellness foods, and beverage-alcohol. Tilray Brands is on a mission to change people’s lives for the better – one person at a time - by inspiring and empowering the worldwide community to live their very best life, enhanced by moments of connection and wellbeing. Patients and consumers trust Tilray Brands to be the most responsible, trusted and market leading cannabis and consumer products company in the world with a portfolio of innovative, high-quality, and beloved brands that address the needs of the consumers, customers, and patients we serve. A pioneer in cannabis research, cultivation, and distribution, today Tilray Brands’ unprecedented and diversified production platform supports a portfolio of best-in-class brands in over 20 countries including comprehensive adult-use and medical cannabis offerings, hemp-based foods, and craft beverages across North America, Europe, Australia, and Latin America.

For more information on Tilray Brands, visit Tilray Brands, Inc. and follow @Tilray on Instagram, Twitter, Facebook, and LinkedIn.

__________

Forward-Looking Statements

Certain statements in this communication that are not historical facts constitute forward-looking information or forward-looking statements (together, “forward-looking statements”) under Canadian and U.S. securities laws and within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, that are intended to be subject to the “safe harbor” created by those sections and other applicable laws. Forward-looking statements can be identified by words such as “forecast,” “future,” “should,” “could,” “enable,” “potential,” “contemplate,” “believe,” “anticipate,” “estimate,” “plan,” “expect,” “intend,” “may,” “project,” “will,” “would” and the negative of these terms or similar expressions, although not all forward-looking statements contain these identifying words. Certain material factors, estimates, goals, projections, or assumptions were used in drawing the conclusions contained in the forward-looking statements throughout this communication. Forward-looking statements include statements regarding our intentions, beliefs, projections, outlook, analyses, or current expectations concerning, among other things, the Company’s ability to commercialize new and innovative products worldwide. Many factors could cause actual results, performance, or achievement to be materially different from any forward-looking statements, and other risks and uncertainties not presently known to the Company or that the Company deems immaterial could also cause actual results or events to differ materially from those expressed in the forward-looking statements contained herein. For a more detailed discussion of these risks and other factors, see the most recently filed annual information form of Tilray and the Annual Report on Form 10-K (and other periodic reports filed with the SEC) of Tilray made with the SEC and available on EDGAR. The forward-looking statements included in this communication are made as of the date of this communication and the Company does not undertake any obligation to publicly update such forward-looking statements to reflect new information, subsequent events, or otherwise unless required by applicable securities laws.

Contacts:
Media:
Jaydon Case
news@tilray.com

Investors
Raphael Gross
203-682-8253
Raphael.Gross@icrinc.com

TILRAY RENEWS DISTRIBUTION AGREEMENT WITH GREAT NORTH DISTRIBUTORS FOR CANNABIS SALES ACROSS CANADA WITH NEWLY EXPANDED BRAND PORTFOLIO

TILRAY RENEWS DISTRIBUTION AGREEMENT WITH GREAT NORTH DISTRIBUTORS FOR CANNABIS SALES ACROSS CANADA WITH NEWLY EXPANDED BRAND PORTFOLIO

Great North will continue to be the exclusive representative for Tilray’s full portfolio of recreational cannabis products across the Canadian marketplace, with the exception of Quebec. Tilray’s market-leading cannabis portfolio includes Good Supply, Riff, Solei, Canaca, The Batch, Chowie Wowie, and newly acquired Redecan, Original Stash, and Bake Sale.

Broken Coast Ranks #1 at the Budtender’s Association Collectors Cup

TORONTO – September 29, 2022 – Tilray Brands, Inc. ("Tilray" or the "Company") (Nasdaq: TLRY; TSX: TLRY), a leading global cannabis and consumer packaged goods company, today announced that its heritage Canadian craft-cannabis brand, Broken Coast, has ranked number one for its Sunset Sherbet flower at the Collector's Cup b.lounge edition hosted by Budtenders Association and CannaReps.

With 75 full reviews, the ranking involved judgment of each cultivar’s physical appeal, aromatic profile, and blind taste tests. With the guidance of a certified cannabis sommelier and the CannaReps Cannabis Quality Grading Tool to input scores, Broken Coast came in at number one for the highest score in each category during each trial session.

Sunset Sherbet is one of the most popular cultivars ever grown by Broken Coast. Exhibiting dense indica flowers with deep purple and silver colouration, the large calyxes are covered so thickly in glandular trichomes they're almost white. With the most abundant terpenes being caryophyllene, linalool, and myrcene, Sunset Sherbet is a fruit-forward strain that evokes the taste and aromas of strawberries and guava.

"We are honored to receive top ranking from the Budtender’s Association, leaders in education and cannabis research in partnership with Canada’s Budtenders,” says Kyle Asselstine, Broken Coast Brand Manager.

Broken Coast’s craft cannabis flower, including Sunset Sherbet and Amnesia Haze, is available in select markets across Canada, including British Columbia, Ontario, and Alberta.

About Broken Coast  

Founded in 2013 in British Columbia, Canada, Broken Coast is a heritage cannabis brand widely recognized for setting the standard for craft cannabis in Canada. Leveraging proprietary growing practices perfected for each cultivar, Broken Coast delivers the ultimate true expression out of each cannabis plant.  With relentless dedication to craft growing, Broken Coast specializes in growing small-batch, single strain, hand-trimmed, and naturally slow-cured buds delivering the highest-grade cannabis to uphold the quality and reputation that BC bud has earned worldwide. 

For more information on where to find Broken Coast’s summer lineup, visit www.brokencoast.com and follow @brokencoast.ca on Instagram and @brokencoastltd on Twitter.  

 

About Tilray Brands

Tilray Brands, Inc. (Nasdaq: TLRY and TSX: TLRY) is a leading global cannabis-lifestyle and consumer packaged goods company with operations in Canada, the United States, Europe, Australia, and Latin America that is changing people’s lives for the better – one person at a time – by inspiring and empowering the worldwide community to live their very best life by providing them with products that meet the needs of their mind, body, and soul and invoke a sense of wellbeing. Tilray’s mission is to be the trusted partner for its patients and consumers by providing them with a cultivated experience and health and wellbeing through high-quality, differentiated brands and innovative products. A pioneer in cannabis research, cultivation, and distribution, Tilray’s unprecedented production platform supports over 20 brands in over 20 countries, including comprehensive cannabis offerings, hemp-based foods, and alcoholic beverages.

For more information on Tilray, visit Tilray Brands, Inc. and follow @tilray on Instagram, Twitter, Facebook, and LinkedIn.

________

Forward-Looking Statements

Certain statements in this communication that are not historical facts constitute forward-looking information or forward-looking statements (together, “forward-looking statements”) under Canadian securities laws and within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, that are intended to be subject to the “safe harbor” created by those sections and other applicable laws. Forward-looking statements can be identified by words such as “forecast,” “future,” “should,” “could,” “enable,” “potential,” “contemplate,” “believe,” “anticipate,” “estimate,” “plan,” “expect,” “intend,” “may,” “project,” “will,” “would” and the negative of these terms or similar expressions, although not all forward-looking statements contain these identifying words. Certain material factors, estimates, goals, projections, or assumptions were used in drawing the conclusions contained in the forward-looking statements throughout this communication. Forward-looking statements include statements regarding our intentions, beliefs, projections, outlook, analyses, or current expectations concerning, among other things, the Company’s ability to commercialize new and innovative products worldwide. Many factors could cause actual results, performance, or achievement to be materially different from any forward-looking statements, and other risks and uncertainties not presently known to the Company or that the Company deems immaterial could also cause actual results or events to differ materially from those expressed in the forward-looking statements contained herein. For a more detailed discussion of these risks and other factors, see the most recently filed annual information form of Tilray and the Annual Report on Form 10-K (and other periodic reports filed with the SEC) of Tilray made with the SEC and available on EDGAR. The forward-looking statements included in this communication are made as of the date of this communication and the Company does not undertake any obligation to publicly update such forward-looking statements to reflect new information, subsequent events, or otherwise unless required by applicable securities laws.

 

Contacts:

Tilray Global:
Kaitlin Macapagal
news@tilray.com

Investors
Raphael Gross
203-682-8253
Raphael.Gross@icrinc.com

Tilray Medical Relaunches Cannabis Oral Solution Across Ireland

Tilray Medical Relaunches Cannabis Oral Solution Across Ireland

Tilray Brands, Inc. ("Tilray" or the "Company") (Nasdaq: TLRY; TSX: TLRY), a leading global cannabis company inspiring and empowering the worldwide community to live their very best life, today announced that it has successfully relaunched its EU GMP-produced medical cannabis oral solution in Ireland under the country’s Medical Cannabis Access Program (MCAP). Tilray’s approved product has also recently received reimbursement approval, which gives patients cost reimbursement and ensures more eligible patients can access quality medical cannabis under Ireland’s MCAP.

Tilray Brands, Inc. to Announce First Quarter Fiscal 2023 Financial Results on October 7, 2022

NEW YORK and LEAMINGTON, Ontario, September 23, 2022 (GLOBE NEWSWIRE) – Tilray Brands, Inc. (“Tilray” or the “Company”) (Nasdaq: TLRY; TSX: TLRY), a leading global cannabis-lifestyle and consumer packaged goods company inspiring and empowering the worldwide community to live their very best life, today announced that the Company will release financial results for its first quarter fiscal 2023 ended August 31, 2022 before financial markets open on October 7, 2022.

Live Audio Webcast:

Tilray Brands executives will host a live audio webcast to discuss these results at 8:30 am Eastern Time which can be accessed on the Investors section of Tilray's website at www.Tilray.com. A replay will be available and archived after the live webcast.

Additionally, the live audio webcast will be syndicated on the www.Public.com investor app. Tilray Brands’ partnership with Public.com is designed to make company news, investor information, and leadership vision more discoverable among retail investors.

Retail Investor Q&A:

Tilray Brands shareholders can submit and upvote questions to the executive team via shareholder Q&A platform Say Technologies beginning today and until October 6, 2022. To submit questions ahead of the webcast, please visit the Say platform https://app.saytechnologies.com/tilray-brands-2023-q1.

About Tilray Brands

Tilray Brands, Inc. (Nasdaq: TLRY; TSX: TLRY), is a leading global cannabis-lifestyle and consumer packaged goods company with operations in Canada, the United States, Europe, Australia, and Latin America that is changing people's lives for the better – one person at a time. Tilray Brands delivers on this mission by inspiring and empowering the worldwide community to live their very best life, enhanced by moments of connection and wellbeing. Patients and consumers trust Tilray Brands to be the most responsible, trusted and market leading cannabis consumer products company in the world with a portfolio of innovative, high-quality and beloved brands that address the needs of the consumers, customers and patients we serve. A pioneer in cannabis research, cultivation, and distribution, Tilray Brands’ unprecedented production platform supports over 20 brands in over 20 countries, including comprehensive cannabis offerings, hemp-based foods, and craft beverages.

For more information on Tilray Brands, visit www.Tilray.com and follow @tilray

 

For further information:

Media: Berrin Noorata, news@tilray.com

Investors: Raphael Gross, (203) 682-8253, Raphael.Gross@icrinc.com

Tilray Medical Receives Approval to Extend Market Authorization in Italy

Tilray Medical Receives Approval to Extend Market Authorization in Italy

Tilray Brands, Inc. ("Tilray" or the "Company") (Nasdaq: TLRY; TSX: TLRY), a leading global cannabis company inspiring and empowering the worldwide community to live their very best life, today announced that FL Group S.R.L. (“FL Group”), a division of Tilray Medical in Italy, has received approval from the Italian Ministry of Health to import and distribute Tilray’s medical cannabis oral solution THC25 across the country.

Tilray Brands, Inc. Reports Record Fiscal Year 2022 Results

Tilray Brands, Inc. Reports Record Fiscal Year 2022 Results

Tilray Brands, Inc. (“Tilray” or the “Company”) (Nasdaq: TLRY; TSX: TLRY), a leading global cannabis-lifestyle and consumer packaged goods company inspiring and empowering the worldwide community to live their very best life, today reported financial results for the fourth quarter and full fiscal year ended May 31, 2022.

Tilray Brands’ Potently Canadian Cannabis Brand, CANACA Joins this Year’s Calgary Stampede and Releases ‘Wild West’ Product Lineup

Tilray Brands’ Potently Canadian Cannabis Brand, CANACA Joins this Year’s Calgary Stampede and Releases ‘Wild West’ Product Lineup

CANACA is celebrating the Calgary Stampede at the legendary Wildhorse Saloon where the brand is hosting a western lounge featuring Stampede-inspired activations and limited-edition merchandise.

Along with the ‘Wild West’ activation, consumers can check out CANACA’s greatest product hits available now in Calgary and nationwide across Canada

Tilray Brands Announces Definitive Agreement With Hexo Corp. Related to Hexo’s Senior Secured Convertible Note

Tilray Brands Announces Definitive Agreement With Hexo Corp. Related to Hexo’s Senior Secured Convertible Note

-- Canada’s Top Two Cannabis Market Leaders to Join Forces, Strengthening Operations and Unlocking up to US$80 Million of Shared Cost Synergies -- Strategic Alliance Establishes Collaboration Agreement for Product Innovation, Including Optimizing Cannabis 2.0 Categories (Pre-Rolls, Beverages and Edibles), as well as Cannabis 3.0 Wellness Products --

Tilray Brands, Inc. Reports Third Quarter Fiscal Year 2022 Financial Results

Tilray Brands, Inc. Reports Third Quarter Fiscal Year 2022 Financial Results

Tilray Brands, Inc. Reports Third Quarter Fiscal Year 2022 Financial Results

Good Supply Brand Expands Its Award-Winning Cannabis Portfolio with Hash Bats™; A New ‘Hard-Hitting’ Infused Pre-Roll

Good Supply Brand Expands Its Award-Winning Cannabis Portfolio with Hash Bats™; A New ‘Hard-Hitting’ Infused Pre-Roll

Hash Bats™ are made to provide consumers with an elevated and uncompromisable experience, maintaining the brand's high-quality pre-roll standards with an even increased potency level for that extra impact. At 0.5g, the size helps to minimize resin build & harshness so that consumers aren't compromising on the smoking experience for higher potency, with an extra hit of hash.

SweetWater Brewing Company continues rapid expansion with distribution rollout across Washington & Oregon

SweetWater Brewing Company continues rapid expansion with distribution rollout across Washington & Oregon

SweetWater Brewing Company, a subsidiary of Tilray Brands, Inc., has announced its continued westward expansion into both Washington and Oregon, with distribution partner Columbia Distributing, keeping up the momentum after the announcement of its launch into California earlier this month.

Tilray Launches Medical Cannabis Products in Malta

LEAMINGTON, ONTARIO February 17, 2022 – Tilray Brands, Inc. ("Tilray" or the "Company") (Nasdaq: TLRY; TSX: TLRY), a leading global cannabis-lifestyle and consumer packaged goods company inspiring and empowering the worldwide community to live their very best life, today announced that its medical cannabis division, Tilray Medical, has completed its first sale of medical cannabis in Malta.  Tilray’s EU-GMP medical cannabis products are now available in pharmacies across Malta, providing patients with safe and reliable access to high-quality medical cannabis.

 

Denise Faltischek, Tilray’s Chief Strategy Officer and Head of International Business, said, “As demand for cannabis continues to grow across Europe, we’re incredibly proud to partner with established and reliable distribution partners to supply new markets with high-quality medical cannabis which patients can rely on.”

 

In Malta, patients may obtain prescriptions for medical cannabis and a medical cannabis card through family doctors.  Medical cannabis cards are issued by Malta’s Superintendent of Public Health.

 

Tilray has a pioneering track record as a company committed to making EU GMP-certified, pharmaceutical-grade medical cannabis products available to patients in need around the world and was the first to successfully export medical cannabis from North America and import medical cannabis products into the E.U. in 2016.

 

About Tilray Medical 

Tilray Medical is dedicated to transforming lives and fostering dignity for patients in need through safe and reliable access to a global portfolio of medical cannabis brands, including Tilray, Aphria, Broken Coast, and Symbios. Tilray grew from being one of the first companies to become an approved licensed producer of medical cannabis in Canada to building the first GMP-certified cannabis production facilities in Europe, first in Portugal and later in Germany. Today, Tilray Medical is one of the biggest suppliers of medical cannabis brands to patients, physicians, hospitals, pharmacies, researchers, and governments, in 20 countries and across five continents.

 

For more information on Tilray Medical, visit Tilray Medical Canada, Tilray Medical Australia, Tilray Medical Australia-New Zealand, Tilray Medical Europe

 

About Tilray Brands

Tilray Brands, Inc. (Nasdaq: TLRY; TSX: TLRY), is a leading global cannabis-lifestyle and consumer packaged goods company with operations in Canada, the United States, Europe, Australia, and Latin America that is changing people's lives for the better – one person at a time.  Tilray Brands delivers on this mission by inspiring and empowering the worldwide community to live their very best life and providing access to products that meet the needs of their mind, body, and soul while invoking wellbeing. Patients and consumers trust Tilray Brands to deliver a cultivated experience and health and wellbeing through high-quality, differentiated brands and innovative products. A pioneer in cannabis research, cultivation, and distribution, Tilray’s unprecedented production platform supports over 20 brands in over 20 countries, including comprehensive cannabis offerings, hemp-based foods, and craft beverages.

For more information on how we open a world of wellbeing, visit www.Tilray.com.

 

Forward-Looking Statements

Certain statements in this communication that are not historical facts constitute forward-looking information or forward-looking statements (together, “forward-looking statements”) under Canadian securities laws and within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, that are intended to be subject to the “safe harbor” created by those sections and other applicable laws. Forward-looking statements can be identified by words such as “forecast,” “future,” “should,” “could,” “enable,” “potential,” “contemplate,” “believe,” “anticipate,” “estimate,” “plan,” “expect,” “intend,” “may,” “project,” “will,” “would” and the negative of these terms or similar expressions, although not all forward-looking statements contain these identifying words. Certain material factors, estimates, goals, projections or assumptions were used in drawing the conclusions contained in the forward-looking statements throughout this communication. Forward-looking statements include statements regarding our intentions, beliefs, projections, outlook, analyses or current expectations concerning, among other things: expectations regarding the performance and scale of the Company, including Tilray Medical; and the Company’s ability to expand its offering to patients worldwide, including via Tilray Medical. Many factors could cause actual results, performance or achievement to be materially different from any forward-looking statements, and other risks and uncertainties not presently known to the Company or that the Company deems immaterial could also cause actual results or events to differ materially from those expressed in the forward-looking statements contained herein. For a more detailed discussion of these risks and other factors, see the most recently filed annual information form of Tilray and the Annual Report on Form 10-K (and other periodic reports filed with the SEC) of Tilray made with the SEC and available on EDGAR. The forward-looking statements included in this communication are made as of the date of this communication and the Company does not undertake any obligation to publicly update such forward-looking statements to reflect new information, subsequent events or otherwise unless required by applicable securities laws.

For further information:

Media, Tilray Global: news@tilray.com

Investors

Raphael Gross

203-682-8253

Raphael.Gross@icrinc.com

 

 

Breckenridge Distillery Announces Second Series of ‘Super’ Sexy Motor Oil Launching in Limited Edition for Valentine’s Day

Breckenridge Distillery Announces Second Series of ‘Super’ Sexy Motor Oil Launching in Limited Edition for Valentine’s Day

As the story goes, Breckenridge Brewery took Breckenridge Distillery’s freshly dumped Bourbon Whiskey barrels and aged their Imperial Oatmeal Stout in them. This time, adding coffee and coconut. After they were done, Breckenridge Distillery took those barrels back and filled them with their award-winning Bourbon Whiskey and aged it for over a year to create ‘Super’ Sexy Motor Oil.

Tilray Brands Consolidates its Global Medical Offering into Tilray Medical, a Comprehensive Portfolio of Brands and Products

Tilray Brands Consolidates its Global Medical Offering into Tilray Medical, a Comprehensive Portfolio of Brands and Products

Tilray Brands, Inc. ("Tilray" or the "Company") (Nasdaq: TLRY; TSX: TLRY), a leading global cannabis-lifestyle and consumer packaged goods company inspiring and empowering the worldwide community to live their very best life, today announced the launch of Tilray Medical, a global medical platform that unifies the Company's medical cannabis brands under one strategy, mission, and vision.